Akinori Nakayama1, Hisamitsu Ide2, Yan Lu3, Ayano Takei4, Kazunori Fukuda4, Akiyoshi Osaka1, Gaku Arai1, Shigeo Horie3, Hiroshi Okada1, Kazutaka Saito1. 1. Department of Urology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan. 2. Department of Urology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan; ihisamit@dokkyomed.ac.jp. 3. Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan. 4. Collaborative Research Center, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
Abstract
BACKGROUND/AIM: Curcumin is a natural compound of turmeric, which inhibits prostate cancer cell proliferation. This study examined whether treatment of LNCaP prostate cancer cells with the combination of curcumin and dutasteride, a 5-alpha reductase inhibitor, affect proliferation and the amount of testosterone and dihydrotestosterone. MATERIALS AND METHODS: LNCaP Cells were incubated with curcumin or the combination of curcumin and dutasteride and cell proliferation was measured at 72 h. LC-MS/MS was used to determine testosterone and dihydrotestosterone concentrations in prostate cancer cells. RESULTS: Curcumin combined with dutasteride suppressed proliferation and affected apoptosis of LNCaP cells. The combination of curcumin and dutasteride also reduced the amount of testosterone and dihydrotestosterone in LNCaP cells. The secretion of prostate-specific antigen was inhibited by the combination treatment in a dose-dependent manner. CONCLUSION: Treatment with the combination of curcumin and dutasteride may interfere with the intra-tumoral androgen activity. Copyright
BACKGROUND/AIM: Curcumin is a natural compound of turmeric, which inhibits prostate cancer cell proliferation. This study examined whether treatment of LNCaP prostate cancer cells with the combination of curcumin and dutasteride, a 5-alpha reductase inhibitor, affect proliferation and the amount of testosterone and dihydrotestosterone. MATERIALS AND METHODS:LNCaP Cells were incubated with curcumin or the combination of curcumin and dutasteride and cell proliferation was measured at 72 h. LC-MS/MS was used to determine testosterone and dihydrotestosterone concentrations in prostate cancer cells. RESULTS:Curcumin combined with dutasteride suppressed proliferation and affected apoptosis of LNCaP cells. The combination of curcumin and dutasteride also reduced the amount of testosterone and dihydrotestosterone in LNCaP cells. The secretion of prostate-specific antigen was inhibited by the combination treatment in a dose-dependent manner. CONCLUSION: Treatment with the combination of curcumin and dutasteride may interfere with the intra-tumoral androgen activity. Copyright
Authors: Anna Bill-Axelson; Lars Holmberg; Mirja Ruutu; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Christer Busch; Stig Nordling; Hans Garmo; Juni Palmgren; Hans-Olov Adami; Bo Johan Norlén; Jan-Erik Johansson Journal: N Engl J Med Date: 2005-05-12 Impact factor: 91.245
Authors: Robert L Grubb; Gerald L Andriole; Matthew C Somerville; Chrysa Mahoney; Michael J Manyak; Ramiro Castro Journal: J Urol Date: 2012-09-25 Impact factor: 7.450
Authors: A P Cumming; S N Hopmans; S Vukmirović-Popović; W C Duivenvoorden Journal: Prostate Cancer Prostatic Dis Date: 2011-08-09 Impact factor: 5.554